Skip to content
healthcare.dev

Cystografin Dilute

NDC 0270-1410, diatrizoate meglumine, injection, solution, from BRACCO DIAGNOSTICS INC.

Product NDC
0270-1410
Status
Listed
Labeler
BRACCO DIAGNOSTICS INC
Dosage form
INJECTION, SOLUTION
Route
INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA010040
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0270-1410 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIATRIZOATE MEGLUMINE180 mg/mL

Pharmacologic classes

Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]

Package NDCNDC-11Package
0270-1410-300027014103010 BOTTLE in 1 PACKAGE (0270-1410-30) / 300 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e56882fa-4a30-43b1-bb6b-f7d4a4101c4e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0270-1410

Use it

Look up 0270-1410 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0270-1410 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0270-1410. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.